Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.27 USD | +0.40% | -0.32% | -28.51% |
27/03 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
27/03 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
Business Summary
Number of employees: 895
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Hospital
58.2
%
| - | - | 187 | 58.2 % | - |
Private Office
29.8
%
| - | - | 96 | 29.8 % | - |
Other
12.0
%
| - | - | 39 | 12.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 268 | 100.0 % | 321 | 100.0 % | +20.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 27/23/27 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 05/23/05 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Mark P. Graves
CMP | Compliance Officer | 59 | 01/18/01 |
Ricci Whitlow
COO | Chief Operating Officer | 55 | 03/23/03 |
William Hulse
ADM | Chief Administrative Officer | 50 | 02/19/02 |
David H. Mason
CTO | Chief Tech/Sci/R&D Officer | 77 | 19/14/19 |
K. Newton
BRD | Director/Board Member | 61 | 19/19/19 |
Eric Smith
SAM | Sales & Marketing | - | 01/21/01 |
Kim Moller
SAM | Sales & Marketing | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 02/20/02 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 08/21/08 |
K. Newton
BRD | Director/Board Member | 61 | 19/19/19 |
M. Wilsey
CHM | Chairman | 71 | 19/19/19 |
James Bierman
BRD | Director/Board Member | 71 | 19/19/19 |
Martin Sutter
BRD | Director/Board Member | 68 | 02/20/02 |
Joe Capper
CEO | Chief Executive Officer | 60 | 27/23/27 |
Michael Giuliani
BRD | Director/Board Member | 69 | 20/20/20 |
Cato Laurencin
BRD | Director/Board Member | 65 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 147,583,218 | 144,272,178 ( 97.76 %) | 0 | 97.76 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.51% | 925M | |
-20.60% | 128M | |
-7.82% | 67.46M | |
+6.64% | 60.58M | |
+0.60% | 51.45M |
- Stock Market
- Equities
- MDXG Stock
- Company MiMedx Group, Inc.